"Organometallic Compounds" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A class of compounds of the type R-M, where a C atom is joined directly to any other element except H, C, N, O, F, Cl, Br, I, or At. (Grant & Hackh's Chemical Dictionary, 5th ed)
| Descriptor ID |
D009942
|
| MeSH Number(s) |
D02.691
|
| Concept/Terms |
Organometallic Compounds- Organometallic Compounds
- Compounds, Organometallic
- Metallo-Organic Compounds
- Compounds, Metallo-Organic
- Metallo Organic Compounds
- Metalloorganic Compounds
- Compounds, Metalloorganic
|
Below are MeSH descriptors whose meaning is more general than "Organometallic Compounds".
Below are MeSH descriptors whose meaning is more specific than "Organometallic Compounds".
This graph shows the total number of publications written about "Organometallic Compounds" by people in this website by year, and whether "Organometallic Compounds" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 2 | 0 | 2 |
| 1997 | 1 | 0 | 1 |
| 1999 | 1 | 0 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 2 | 0 | 2 |
| 2005 | 1 | 1 | 2 |
| 2006 | 5 | 2 | 7 |
| 2007 | 0 | 1 | 1 |
| 2008 | 1 | 0 | 1 |
| 2009 | 5 | 0 | 5 |
| 2010 | 2 | 1 | 3 |
| 2011 | 6 | 6 | 12 |
| 2012 | 3 | 1 | 4 |
| 2013 | 4 | 2 | 6 |
| 2014 | 3 | 3 | 6 |
| 2015 | 3 | 1 | 4 |
| 2016 | 3 | 3 | 6 |
| 2017 | 2 | 3 | 5 |
| 2018 | 2 | 2 | 4 |
| 2019 | 2 | 1 | 3 |
| 2020 | 2 | 1 | 3 |
| 2021 | 1 | 2 | 3 |
| 2023 | 3 | 0 | 3 |
| 2024 | 2 | 1 | 3 |
| 2025 | 1 | 2 | 3 |
| 2026 | 1 | 1 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Organometallic Compounds" by people in Profiles.
-
Light It Up! The Use of DOTATATE in Diagnosis and Treatment of Neuroendocrine Neoplasms. Clin Lab Med. 2026 Sep; 46(3):607-622.
-
18F-FDOPA PET/CT for neuroendocrine tumors in multiple endocrine neoplasia type 1. Front Endocrinol (Lausanne). 2026; 17:1849746.
-
Nanoscale Donor-Acceptor Covalent Organic Frameworks for Mitochondria-Targeted Sonodynamic Therapy and Antitumor Immunity. J Am Chem Soc. 2025 07 23; 147(29):25622-25634.
-
Association of integrated biomarkers and progression-free survival prediction in patients with gastroenteropancreatic neuroendocrine tumors undergoing [177Lu]Lu-DOTA-TATE therapy. Theranostics. 2025; 15(13):6444-6453.
-
Composite spin probes with adjustable oxygen sensitivity for pulse electron paramagnetic resonance imaging. Magn Reson Med. 2025 May; 93(5):2239-2249.
-
Surgery enhances the effectiveness of peptide receptor radionuclide therapy in metastatic gastroenteropancreatic neuroendocrine tumors. Surgery. 2025 01; 177:108834.
-
Quantitative SPECT/CT Metrics in Early Prediction of [177Lu]Lu-DOTATATE Treatment Response in Gastroenteropancreatic Neuroendocrine Tumor Patients. J Nucl Med. 2024 10 01; 65(10):1584-1590.
-
Quantitative SSTR-PET/CT: a potential tool for predicting everolimus response in neuroendoctine tumour patients. Radiol Oncol. 2024 09 01; 58(3):348-356.
-
Nanoscale Covalent Organic Framework with Staggered Stacking of Phthalocyanines for Mitochondria-Targeted Photodynamic Therapy. J Am Chem Soc. 2024 01 10; 146(1):849-857.
-
Accuracy of DOTATATE PET imaging in the preoperative planning of small bowel neuroendocrine tumor resection. J Surg Oncol. 2023 Dec; 128(7):1072-1079.